HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Takayanagi Selected Research

Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)

3/2009[Molecular mechanism of bone destruction].
4/2007[Osteoclast differentiation and activation].
2/2005Stat1-mediated cytoplasmic attenuation in osteoimmunology.
1/2005Osteoimmunological insight into bone damage in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Takayanagi Research Topics

Disease

16Bone Resorption
01/2019 - 05/2002
12Arthritis (Polyarthritis)
08/2020 - 06/2003
11Inflammation (Inflammations)
01/2021 - 12/2005
8Osteoporosis
03/2015 - 08/2005
6Rheumatoid Arthritis
01/2020 - 01/2007
6Autoimmune Diseases (Autoimmune Disease)
01/2019 - 02/2008
4Neoplasms (Cancer)
01/2020 - 02/2010
3Experimental Arthritis
08/2020 - 02/2008
3Osteopetrosis
03/2008 - 04/2004
2Neoplasm Metastasis (Metastasis)
01/2020 - 01/2019
2Bone Diseases (Bone Disease)
03/2014 - 12/2005
2Rheumatic Diseases (Rheumatism)
12/2009 - 05/2009
1Hip Dislocation
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021
1Osteomyelitis
01/2021
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2021
1Hypertrophy
08/2020
1Necrosis
06/2020
1Carcinogenesis
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Immune System Diseases (Immune Disorders)
01/2019
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2019
1Osteolysis
01/2019
1Communicable Diseases (Infectious Diseases)
01/2018
1Lung Neoplasms (Lung Cancer)
10/2017
1Osteosarcoma (Osteogenic Sarcoma)
01/2017
1Bone Fractures (Bone Fracture)
03/2016
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
03/2015
1Infertility (Sterility)
05/2014
1Cleidocranial Dysplasia (Cleidocranial Dysostosis)
01/2014
1Mitochondrial Diseases (Mitochondrial Disease)
11/2012
1Joint Diseases (Joint Disease)
05/2012
1Metabolic Bone Diseases (Osteopenia)
03/2012
1Vitamin E Deficiency
03/2012
1Squamous Cell Carcinoma of Head and Neck
02/2010
1Mouth Neoplasms (Oral Cancer)
02/2010
1Chagas Disease (American Trypanosomiasis)
07/2009

Drug/Important Bio-Agent (IBA)

11CytokinesIBA
01/2021 - 12/2005
11LigandsIBA
01/2020 - 01/2005
6Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2004
4Interleukin-17 (Interleukin 17)IBA
01/2021 - 01/2012
4Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
03/2009 - 01/2005
3Phosphotransferases (Kinase)IBA
01/2020 - 03/2008
3Semaphorin-3AIBA
01/2019 - 05/2012
3Antirheumatic Agents (DMARD)IBA
12/2009 - 01/2007
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2010
2AutoantibodiesIBA
08/2020 - 03/2015
2Immunoglobulin G (IgG)IBA
01/2019 - 03/2015
2DenosumabFDA Link
01/2019 - 10/2017
2CollagenIBA
01/2016 - 01/2014
2AntigensIBA
01/2015 - 01/2014
2PlasticsIBA
01/2015 - 01/2014
2InterleukinsIBA
04/2010 - 11/2006
2RANK LigandIBA
09/2009 - 12/2005
2Fc Receptors (Fc Receptor)IBA
07/2007 - 04/2004
1PeriostinIBA
01/2022
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Butyrates (Butyrate)IBA
08/2020
1Collagen Type II (Type II Collagen)IBA
08/2020
1chlorine dioxide (Alcide)IBA
06/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2020
1Proto-Oncogene Proteins c-hckIBA
01/2020
1Stromal Interaction MoleculesIBA
01/2019
1Chemotactic FactorsIBA
01/2019
1Immunoglobulin E (IgE)IBA
01/2019
1Pharmaceutical PreparationsIBA
10/2017
1Gonadal Steroid Hormones (Sex Hormones)IBA
10/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1FollistatinIBA
01/2017
1Carrier Proteins (Binding Protein)IBA
01/2017
1Immunologic Factors (Immunomodulators)IBA
12/2015
1AntibodiesIBA
12/2015
1Hormones (Hormone)IBA
09/2015
1ChemokinesIBA
09/2015
1Antigen-Antibody Complex (Immune Complex)IBA
03/2015
1theaflavin-3,3'-digallateIBA
03/2015
1EndotoxinsIBA
05/2014
1ibrutinibIBA
03/2014
1Transcription Factors (Transcription Factor)IBA
01/2014
1Class Ia Phosphatidylinositol 3-KinaseIBA
12/2012
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
12/2012
1Adenosine Triphosphate (ATP)IBA
11/2012
1bone resorption factorIBA
11/2012
1Mitochondrial DNA (mtDNA)IBA
11/2012
1MineralsIBA
11/2012
1CD100 antigenIBA
11/2012
1OsteoprotegerinIBA
05/2012
1CateninsIBA
03/2012
1Tissue Plasminogen Activator (Alteplase)FDA Link
03/2012
1Tocopherols (Tocopherol)IBA
03/2012
1ThiazolidinedionesIBA
10/2010
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2010
1Conditioned Culture MediaIBA
02/2010
1Parathyroid Hormone-Related ProteinIBA
02/2010
1LipopolysaccharidesIBA
09/2009

Therapy/Procedure

2Therapeutics
07/2007 - 06/2003
1Disarticulation
01/2022
1Drug Therapy (Chemotherapy)
11/2019
1Oral Administration
01/2019